Stay updated on MSTT1041A Efficacy/Safety in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the MSTT1041A Efficacy/Safety in Severe Asthma: Clinical Trial page.

Latest updates to the MSTT1041A Efficacy/Safety in Severe Asthma: Clinical Trial page
- CheckyesterdayChange DetectedThe NIH notice about website updates and the shift from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the study-record error page.SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision identifier was updated from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error with the accompanying HTML, and a Home link appears in the footer, indicating access to the study results is blocked.SummaryDifference0.5%

Stay in the know with updates to MSTT1041A Efficacy/Safety in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MSTT1041A Efficacy/Safety in Severe Asthma: Clinical Trial page.